BVT Knock-Out BIIB/ DE000VV2AX55 /
12/06/2024 08:37:40 | Chg.-0.14 | Bid10:02:42 | Ask10:02:42 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
6.09EUR | -2.25% | 6.12 Bid Size: 8,000 |
6.28 Ask Size: 8,000 |
Biogen Inc | 160.40 USD | 31/12/2078 | Call |
GlobeNewswire
11/06
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
GlobeNewswire
11/06
Skyhawk Therapeutics Promotes Clint Musil to Chief Executive Officer and Appoints Co-founder Bill Ha...
GlobeNewswire
11/06
Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer an...
GlobeNewswire
11/06
BIOGEN NOTICE: If You Suffered Losses on Your Biogen Inc. (Nasdaq: BIIB) Investment, You are Reminde...
GlobeNewswire
10/06
BIOGEN INC. (NASDAQ: BIIB) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class ...
GlobeNewswire
10/06
Biogen Inc. Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges BIIB Investors with Losses to C...
GlobeNewswire
10/06
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...
GlobeNewswire
10/06
FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application f...
GlobeNewswire
08/06
BIOGEN CASE DEADLINE: Biogen Inc. (Nasdaq: BIIB) Investors are Reminded of Upcoming July 2024 Legal ...
GlobeNewswire
07/06
BIIB Class Action Reminder: Contact Robbins LLP for Information About Your Rights Against Biogen Inc...
GlobeNewswire
07/06
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Biogen Inc. (BIIB) S...
GlobeNewswire
07/06
DEADLINE ALERT for CMBM, BIIB, DRCT, and FSLY: The Law Offices of Frank R. Cruz Reminds Investors of...
GlobeNewswire
06/06
Class Action Filed Against Biogen Inc. (BIIB) - July 22, 2024 Deadline to Join – Contact The Gross L...
GlobeNewswire
06/06
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Agains...
GlobeNewswire
06/06
Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepin...
GlobeNewswire
06/06
BIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Sub...
GlobeNewswire
06/06
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...
GlobeNewswire
05/06
UPCOMING DEADLINE ALERT: Biogen Inc. (Nasdaq: BIIB) Investors are Encouraged to Contact BFA Law Abou...
GlobeNewswire
05/06
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Biogen Inc. with Losses to ...
GlobeNewswire
05/06
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Biogen...
GlobeNewswire
04/06
Bitterroot Bio Announces Appointment of Georgette Verdin as Chief People Officer and Sherwin Chen as...